CYCLOSET Drug Patent Profile
✉ Email this page to a colleague
When do Cycloset patents expire, and what generic alternatives are available?
Cycloset is a drug marketed by Veroscience and is included in one NDA. There are thirteen patents protecting this drug.
This drug has thirty-three patent family members in thirteen countries.
The generic ingredient in CYCLOSET is bromocriptine mesylate. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the bromocriptine mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cycloset
A generic version of CYCLOSET was approved as bromocriptine mesylate by SANDOZ on January 13th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CYCLOSET?
- What are the global sales for CYCLOSET?
- What is Average Wholesale Price for CYCLOSET?
Summary for CYCLOSET
International Patents: | 33 |
US Patents: | 13 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 54 |
Clinical Trials: | 9 |
Patent Applications: | 3,236 |
Drug Prices: | Drug price information for CYCLOSET |
What excipients (inactive ingredients) are in CYCLOSET? | CYCLOSET excipients list |
DailyMed Link: | CYCLOSET at DailyMed |
Recent Clinical Trials for CYCLOSET
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Heart, Lung, and Blood Institute (NHLBI) | Phase 4 |
Dennis McNamara | Phase 4 |
Jaime Daniel Mondragon | Phase 2/Phase 3 |
Pharmacology for CYCLOSET
Drug Class | Ergot Derivative |
US Patents and Regulatory Information for CYCLOSET
CYCLOSET is protected by one hundred and twenty-six US patents.
Expired US Patents for CYCLOSET
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 8,137,992 | ⤷ Subscribe |
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 5,468,755 | ⤷ Subscribe |
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 7,888,310 | ⤷ Subscribe |
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 8,137,993 | ⤷ Subscribe |
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 5,866,584 | ⤷ Subscribe |
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 8,137,994 | ⤷ Subscribe |
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 5,756,513 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CYCLOSET
See the table below for patents covering CYCLOSET around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
World Intellectual Property Organization (WIPO) | 2010141938 | ⤷ Subscribe | |
Australia | 2259092 | ⤷ Subscribe | |
Austria | 391506 | ⤷ Subscribe | |
Japan | H10502644 | ⤷ Subscribe | |
Portugal | 735863 | ⤷ Subscribe | |
Australia | 2016202572 | BROMOCRIPTINE FORMULATIONS | ⤷ Subscribe |
Japan | 2015515984 | ブロモクリプチン製剤 | ⤷ Subscribe |
>Country | >Patent Number | >Title | >Estimated Expiration |
CYCLOSET Market Analysis and Financial Projection Experimental
More… ↓